Boltz announces $28M seed round and partnership with Pfizer to deploy biomolecular AI models

Boltz closed a $28M seed round with backing from Andreessen Horowitz, Amplify Partners, and Zetta Venture Partners. In tandem, Pfizer and Boltz announced a strategic collaboration to deploy Boltz's biomolecular AI models across Pfizer's drug discovery pipeline for small-molecule and biologics design.